Sysmex, Eisai link up for Alzheimer’s diagnostics
This article was originally published in Clinica
Executive Summary
Sysmex is teaming up with fellow Japanese pharma company Eisai to develop a new generation of diagnostic reagents for dementia, including Alzheimer’s disease.